ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
2019年06月04日 16時00分
Source:
Eisai
エーザイ、人事異動ならびに組織改編を発表
東京, 2019年06月04日 - (JCN Newswire) - エーザイ株式会社は本日、人事異動ならびに組織改編(2019年6月1日付)を以下のとおり発表しました。
2019年6月1日付 人事異動
■グローバル本社
新任務/旧任務/氏名
コーポレートベンチャーインベストメント部 ストラテジックインベストメントオフィサー(理事職)/(入社)/有賀 学
2019年6月1日付 主な組織改編
■ グローバル本社
1. ストラテジックインベストメントオフィサーの設置
コーポレートベンチャーインベストメント(CVI)部に、ストラテジックインベストメントオフィサー(SIO)を設置する。SIOは、CVIプロジェクトを主導するとともに、チーフストラテジーオフィサーおよびチーフフィナンシャルオフィサーと連携し、投資戦略立案ならびに投資先候補の選定を担う。
本リリースの詳細は下記をご参照ください。
https://www.eisai.co.jp/news/2019/news201941.html
概要:エーザイ株式会社
詳細はwww.eisai.co.jpをご覧ください。
Source: Eisai
セクター: バイオテック
Copyright ©2026 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
JCB Contactless Payment Now Available on Taipei Metro
Jul 01, 2026 10:00 JST
Hitachi High-Tech opens Innovation Center Eindhoven in the Netherlands to accelerate open innovation
Jul 01, 2026 00:59 JST
Honda to Commemorate 40th Anniversary of Its First F1(TM) Title
Jul 01, 2026 00:48 JST
Honda Issues "Honda ESG Report 2026"
Jul 01, 2026 00:24 JST
Sharp Signs Memorandum of Understanding with Major Global Satellite Operator SES to Build a Collaboration in Satellite Communication Services
Jul 01, 2026 00:09 JST
Mitsubishi Motors to Bring Authentic Off-Road Performance to Life with its All-New Pajero Cross-Country SUV
Jun 30, 2026 23:46 JST
MHIEC Completes Rebuild of Nagasaki City East Plant
Jun 30, 2026 23:04 JST
NEC Recognized as a Specialist in Gartner(R) Emerging Market Quadrant for Physical AI Services - Established Vendors
Jun 30, 2026 22:47 JST
DENSO and TUV Rheinland Japan Confirm the Practicality of Battery Passport for AESC's Energy Storage Product Using Actual Data
Jun 30, 2026 22:10 JST
Mitsubishi Shipbuilding Receives Order for the MAmmoSS(R) Ammonia Fuel Handling System
Jun 27, 2026 13:16 JST
MHI Study Results Indicate Potential Cost Reductions in the Decarbonization Value Chain Using Green Hydrogen and Ammonia Produced in India
Jun 27, 2026 13:00 JST
Foxconn and Sharp Signs Memorandum of Understanding for Strategic Collaboration in New Business Areas
Jun 27, 2026 12:44 JST
DENSO Group Formulates New Environmental Policy "Eco Vision 2035"
Jun 27, 2026 11:58 JST
JCB and PNB Launch New Platinum Credit Card, Empowering Consumers with Greater Value and Lifestyle Benefits
Jun 26, 2026 19:00 JST
MHIET's 500kW-Class Hydrogen Engine Generator Set Achieves Technology Readiness Level for Commercialization
Jun 24, 2026 02:29 JST
DOCOMO Becomes First in Japan to Deploy Nokia's AI-powered MantaRay AutoPilot for Automated Network Optimization
Jun 24, 2026 02:11 JST
Mitsubishi Power and LNGPH Sign Long-Term Deal for Gas Turbine Parts and Services to Advance Energy Resilience in the Philippines
Jun 24, 2026 01:54 JST
Honda to Rename Rugby Team "TOCHIGI Honda HEAT" to Coincide with the Team's New Base of Operation
Jun 24, 2026 00:36 JST
NEC Participates in NATO CCDCOE's Cyber Defense Exercise "Locked Shields 2026"
Jun 24, 2026 00:13 JST
JCB Contactless Expands to Metro de Madrid Enabling Seamless Tap-to-Ride Access Across the Network
Jun 23, 2026 12:00 JST
More Latest Release >>
Related Release
Eisai Announces Strategic Investment Supported by the UK Government's LSIMF
6/17/2026 1:28:00 PM JST
Eisai Deepens Body of Clinical Evidence for LENVIMA(R) (Lenvatinib) Across Established Indications at ASCO 2026
5/22/2026 12:23:00 AM JST
Merck & Co., Inc., Rahway, NJ, USA and Eisai Provide Update on Phase 3 LITESPARK-012 Trial Evaluating First-Line Combination Treatments for Certain Patients With Advanced Renal Cell Carcinoma (RCC)
4/21/2026 8:52:00 PM JST
Application Submitted for LENVIMA(R) (lenvatinib) in Japan Seeking Approval of Additional Dosage and Administration for Combination with WELIREG(R) (belzutifan) for Renal Cell Carcinoma that has Progressed After Chemotherapy
3/27/2026 8:14:00 PM JST
Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency
3/27/2026 6:19:00 PM JST
Results from Real-World, Long-Term Treatment Persistence with LEQEMBI(R) (lecanemab-irmb) in the United States Presented at AD/PD(TM) 2026
3/23/2026 11:19:00 AM JST
Eisai: Regarding Discontinuation of Administration of "Tazverik(R) Tablets 200mg" (tazemetostat hydrobromide)
3/19/2026 10:54:00 AM JST
Eisai Established the Global Capability Centre in Visakhapatnam, India, to Standardize Global IT Infrastructure Operations and Digital Transformation
3/17/2026 7:49:00 PM JST
Eisai Launches Awareness Campaign on Importance of Sleep Through "Pokemon Sleep" Collaboration
3/12/2026 5:21:00 PM JST
Eisai to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD(TM) 2026 Annual Meeting
3/11/2026 12:07:00 PM JST
More Press release >>